Adial Pharmaceuticals, Inc. (ADIL) vs Bolt Biotherapeutics, Inc. (BOLT)
- Adial Pharmaceuticals, Inc. ADIL 3.49 +11.15%
- Bolt Biotherapeutics, Inc. BOLT 4.06 −4.25%
Adial Pharmaceuticals, Inc. and Bolt Biotherapeutics, Inc. are both Biotechnology companies. Adial Pharmaceuticals, Inc. and Bolt Biotherapeutics, Inc. are of similar size ($8.3M and $8.2M). Adial Pharmaceuticals, Inc. has the higher net margin (0.00% vs −611.5%) and the higher return on invested capital (0.00% vs −143.8%). Across the 13 metrics below, Adial Pharmaceuticals, Inc. leads on 9 and Bolt Biotherapeutics, Inc. on 4.
Valuation
Profitability
| Metric | ADIL | BOLT | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | (654.53%) | 0.00% |
| Net margin | 0.00% | (611.47%) | 0.00% |
| Free cash flow margin | 0.00% | (655.72%) | 0.00% |
| Return on equity | 352.60% | (111.65%) | (56.36%) |
| Return on assets | (322.10%) | (49.62%) | (48.04%) |
| Return on invested capital | 0.00% | (143.75%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack